Abstract
Emerging data suggest that primary dysfunction in the tumor microenvironment is crucial for carcinogenesis. These recent findings make a compelling case for targeting the milieu for cancer chemoprevention as well as therapy. The stroma is an integral part of its physiology, and functionally, one cannot totally dissociate the tumor surrounding from the tumor cells. A thorough understanding of the tumor and stroma will aid us in developing new treatment targets. In this review, we shed light at the key aspects of the carcinogenic process and how oxidative stress and inflammation contribute to this process. We dissect the connection between metastasis and oxidative stress and focus on the key players in the tumor microenvironment that leads to inflammation, oxidative stress and DNA damage. Moreover, we consider the role of inflammation in disease, specifically cancer and metastasis. Finally, we discuss the potential applications in prognosis and cancer treatment.
Keywords: Carcinogenesis, DNA damage, genomic instability, inflammation, oxidative stress, tumor microenvironment, homeostasis, tumorigenesis, cell proliferation, apoptosis, neoplasia, malignant phenotype, mutagenesis, metastasis, DNA mutations
Current Molecular Medicine
Title:The Interplay Between Inflammation and Oxidative Stress in Carcinogenesis
Volume: 12 Issue: 6
Author(s): S. Nowsheen, K. Aziz, T. B. Kryston, N. F. Ferguson and A. Georgakilas
Affiliation:
Keywords: Carcinogenesis, DNA damage, genomic instability, inflammation, oxidative stress, tumor microenvironment, homeostasis, tumorigenesis, cell proliferation, apoptosis, neoplasia, malignant phenotype, mutagenesis, metastasis, DNA mutations
Abstract: Emerging data suggest that primary dysfunction in the tumor microenvironment is crucial for carcinogenesis. These recent findings make a compelling case for targeting the milieu for cancer chemoprevention as well as therapy. The stroma is an integral part of its physiology, and functionally, one cannot totally dissociate the tumor surrounding from the tumor cells. A thorough understanding of the tumor and stroma will aid us in developing new treatment targets. In this review, we shed light at the key aspects of the carcinogenic process and how oxidative stress and inflammation contribute to this process. We dissect the connection between metastasis and oxidative stress and focus on the key players in the tumor microenvironment that leads to inflammation, oxidative stress and DNA damage. Moreover, we consider the role of inflammation in disease, specifically cancer and metastasis. Finally, we discuss the potential applications in prognosis and cancer treatment.
Export Options
About this article
Cite this article as:
Nowsheen S., Aziz K., B. Kryston T., F. Ferguson N. and Georgakilas A., The Interplay Between Inflammation and Oxidative Stress in Carcinogenesis, Current Molecular Medicine 2012; 12 (6) . https://dx.doi.org/10.2174/156652412800792642
DOI https://dx.doi.org/10.2174/156652412800792642 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Transcatheter Embolization Therapy in Liver Cancer
Recent Patents on Medical Imaging The Safety and Efficacy of Parathyroid Hormone (PTH) as a Biological Response Modifier for the Enhancement of Bone Regeneration
Current Drug Safety Cancer Stem Cells: How can we Target them?
Current Medicinal Chemistry Nanoparticles Based on Plasma Proteins for Drug Delivery Applications
Current Pharmaceutical Design Virotherapy as An Approach Against Cancer Stem Cells
Current Gene Therapy Flavonoids in Cancer Prevention
Anti-Cancer Agents in Medicinal Chemistry Current Understanding of HSP90 as a Novel Therapeutic Target: An Emerging Approach for the Treatment of Cancer
Current Pharmaceutical Design Role of Genomic Alterations in HER2 Positive Breast Carcinoma: Focus on Susceptibility and Trastuzumab-therapy
Current Cancer Drug Targets Irreversible Multitargeted ErbB Family Inhibitors for Therapy of Lung and Breast Cancer
Current Cancer Drug Targets Epigenetic Remodeling of Chromatin Architecture: Exploring Tumor Differentiation Therapies in Mesenchymal Stem Cells and Sarcomas
Current Stem Cell Research & Therapy Mortality and Morbidity of HIV Infected Patients Receiving HAART: A Cohort Study
Current HIV Research Scorpion Toxin Polyptides as Therapeutic Agents: An Overview
Protein & Peptide Letters Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Current Pharmaceutical Design Pleural Fluid Analysis for Evaluating Pleural Effusions
Current Respiratory Medicine Reviews Oxidative stress and myocarditis
Current Pharmaceutical Design Identification of Genes Associated with Lung Adenocarcinoma Prognosis
Combinatorial Chemistry & High Throughput Screening Mapping the High Throughput SEREX Technology Screening for Novel Tumor Antigens
Combinatorial Chemistry & High Throughput Screening Understanding Abnormal c-JNK/p38MAPK Signaling in Amyotrophic Lateral Sclerosis: Potential Drug Targets and Influences on Neurological Disorders
CNS & Neurological Disorders - Drug Targets Advances of Inorganic Materials in the Detection and Therapeutic Uses against Coronaviruses
Current Medicinal Chemistry Tumor Suppression by DNA Base Excision Repair
Mini-Reviews in Medicinal Chemistry